Medical Advisors

The Neuro Foundation works closely with a group of health professionals who represent the key specialties involved in Neurofibromatosis care. The main roles of the advisors are to:

  • Provide medical knowledge and training for our own Specialist Advisors and office staff.
  • To help develop and update our factsheets.
  • To assess requests from researchers who want to recruit people from our membership to their studies.
  • To provide a medical and scientific perspective on The Neuro Foundation’s development.

Our Medical Advisors:

Professor Rosalie Ferner

Professor Rosalie Ferner

Chair
Consultant and Professor of Neurology at Guys and St Thomas's Hospital and Chair of the Medical Advisory Board of The Neuro Foundation. Professor Ferner has been national lead for the nationally commissioned NF1 service since 2009, and lead for the London NF2 service since 2010. The aim of the national neurofibromatosis services is to give expert, multi-disciplinary, holistic care to people with complex, multi-system disease. Her specialist clinical work is in tumour suppressor conditions – NF 1 and 2, Schwannomatosis and von Hippel Lindau disease.
Dr Sue Huson

Dr Sue Huson

Consultant Clinical Geneticist, based at St Mary’s Hospital in Manchester. She now specialises completely in the diagnosis and management of the different forms of neurofibromatosis. She is clinical lead for the North of England nationally commissioned Complex NF1 service and works alongside Professor Gareth Evans who leads the Northern NF2 service.
Dr Alison Linington

Dr Alison Linington

MRCP, MRCPysch, Diploma in Psychotheraphy (Bavarian Medical Council)
A medical psychotherapist working full-time in the NHS in Greater Glasgow and Clyde. She trained as a psychiatrist and psychotherapist at the University of Wales and at the Max-Planck Institute in Munich, Germany, specialising at that time in the treatment of eating disorders. She returned to the UK in 2006 and has worked in the NHS as a general adult and liaison psychiatrist and, since 2008, as a medical psychotherapist. She has special interest in the treatment of borderline personality disorder, using a mentalising approach in the way that mental adjustment to illness can affect the quality of life in chronic disease.
Christine Steiger

Christine Steiger

A Consultant Community Paediatrician in The Wirral, Merseyside, having previously worked at Alder Hey Hospital, Liverpool where she set up a follow-up service for children and young people with NF1. This service continues and Christine has established a similar dedicated clinic in The Wirral. The clinic enables families and young people to explore the diagnosis over time and aims to enable the young adults leaving the service to have an understanding of their health and when to seek medical advice. Some families face serious medical concerns for their children and Christine is able to offer discussion and liaison with specialist doctors. In practice much time is used to explore developmental concerns and their implications for education in NF1 patients. Here Christine's background as a community paediatrician, used to multidisciplinary working with conditions such as Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder, Developmental Coordination Disorder and Speech and Language Disorders is invaluable.
Professor Meena Upadhyaya

Professor Meena Upadhyaya

Professor of Medical Genetics at Cardiff University. She obtained her PhD from Cardiff University and gained Fellowship of the Royal College of Pathology (FRCPath), London. Prof Upadhyaya has made substantial contributions to the understanding of molecular basis of a number of genetic conditions including NF1, Fascioscapulohumeral Muscular Dystrophy (FSHD), Legius syndrome, Charcot Marie Tooth disease, Sotos syndrome, Hunters syndrome, plus several others.She has researched NF1 for the past 25 years and has contributed to the mapping and cloning of the NF1 gene. She has been on the Steering Committee of NF1 mutation analysis. Meena Upadhyaya's research has focused on Cancer Genetics of NF1, which is beginning to generate potential therapeutic targets. She is on many research and management committees and has chaired both national and international meetings, as well as supervising numerous post-graduate students for their MD or PhD degrees. She has also published over 160 papers in reputable journals, written 25 book chapters and edited three books.
Chris Bradish

Chris Bradish

Consultant Orthopaedic Surgeon, Great Ormond Street Hospital
Jeremy Fairbank

Jeremy Fairbank

Consultant Orthopaedic Surgeon, Oxford
Henk Giele

Henk Giele

Consultant Plastic Surgeon. Oxford
Oliver Hanemann

Oliver Hanemann

Consultant and Professor of Neurology, Plymouth
Ian Simmons

Ian Simmons

Consultant Paediatric Ophthalmologist, Leeds
Nick Thomas

Nick Thomas

Consultant Neurosurgeon, King’s College London